Protective Effects of Glucagon-Like Peptide-1 Analog on Renal Tubular Injury in Mice on High-Fat Diet

被引:31
作者
Gun, Honglei [1 ]
Li, Hongmei [1 ]
Wang, Bin [2 ,3 ]
Ding, Wei [4 ]
Ling, Lilu [1 ]
Yang, Min [1 ]
Niu, Jianying [1 ]
Gu, Yong [1 ,2 ,3 ]
机构
[1] Fudan Univ, Peoples Hosp Shanghai 5, Div Nephrol, Shanghai, Peoples R China
[2] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai, Peoples R China
[3] Fudan Univ, Inst Nephrol, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Div Nephrol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
GLP-1; ERS; Apoptosis; AT1R; Renal tubular; ENDOPLASMIC-RETICULUM STRESS; SIGNALING PATHWAY; INDUCED APOPTOSIS; ANGIOTENSIN-II; CELL-LINE; KIDNEY; INHIBITION; RECEPTOR; OBESITY; ACTIVATION;
D O I
10.1159/000464118
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: The study aimed to investigate the renoprotective effect of glucagon-like peptide-1 (GLP-1) against renal tubular injury in C57BL/6 mice induced by a high-fat diet (HFD). Methods: Twenty C57BL/6 mice were fed HFD for 12 weeks. Ten of these mice were treated with GLP-1 at 200 pg/kg subcutaneously twice daily for 4 weeks (HFDG group), and the other ten mice received vehicle only (HFD group). Ten mice fed standard rodent chow served as controls (Con group). Body weight, kidney weight, food intake, and systolic blood pressure were measured. The expression of endoplasmic reticulum stress (ERS) markers (BIP, p-eIF2 alpha, ATF4, and CHOP) and apoptosis in the kidney were examined utilizing western blotting, immunohistochemistry and TUNEL, respectively. Angiotensin II and angiotensin II type 1 receptor (AT1R) were examined by ELISA. Human proximal tubule epithelial cells (HK2) were treated with GLP-1(150 nM) followed by treatment with palmitic acid (500 nM [PA]) for 24 h. HK2 cells treated with BSA were used as controls. The protein levels of ERS markers, apoptosis-associated protein, and AT1R were measured by western blotting. Results: Increase of body weight, food intake, and systolic blood pressure was less pronounced in GLP-1 treated HFDG mice compared to HFD mice. The levels of ERS markers (BIP, p-eIF2 alpha, ATF4, and CHOP) and apoptosis decreased following GLP-1 treatment in vivo and in vitro (p<0.05). Increased AT1R induced by HFD and PA were blocked with GLP-1 treatment. In contrast, the level of angiotensin II after GLP-1 treatment was not significantly different between the HFD and HFDG mice. Conclusion: The study indicated that saturated fatty acids induced ERS and apoptosis in the kidney and increased AT1R expression. GLP-1 treatment exerted renoprotective effects against saturated fatty acid-induced kidney tubular cell ERS and apoptosis together with inhibition of AT1R expression in vivo and in vitro. (C) 2017 The Author(s)
引用
收藏
页码:1113 / 1124
页数:12
相关论文
共 32 条
[1]   The Neuroprotective Effect of Liraglutide is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP/PKA/CREB Pathway [J].
Bao, Yi ;
Jiang, Lei ;
Chen, Haiyan ;
Zou, Junjie ;
Liu, Zhimin ;
Shi, Yongquan .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 36 (06) :2366-2378
[2]   Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway [J].
Cao, Jie ;
Dai, Dong-Ling ;
Yao, Long ;
Yu, Hui-Hong ;
Ning, Bo ;
Zhang, Qin ;
Chen, Juan ;
Cheng, Wen-Hui ;
Shen, Wei ;
Yang, Zhao-Xia .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 364 (1-2) :115-129
[3]   Angiotensin II in Type 2 Diabetes Mellitus [J].
Chu, Kwan Yi ;
Leung, Po Sing .
CURRENT PROTEIN & PEPTIDE SCIENCE, 2009, 10 (01) :75-84
[4]   Angiotensinogen levels and obesity in four black populations [J].
Cooper, R ;
Forrester, T ;
Ogunbiyi, O ;
Muffinda, J .
JOURNAL OF HYPERTENSION, 1998, 16 (05) :571-575
[5]   Glucagon-Like Peptide-1 Agonists Protect Pancreatic β-Cells From Upotoxic Endoplasmic Reticulum Stress Through Upregulation of BiP and JunB [J].
Cunha, Daniel A. ;
Ladriere, Laurence ;
Ortis, Fernanda ;
Igoillo-Esteve, Mariana ;
Gurzov, Esteban N. ;
Lupi, Roberto ;
Marchetti, Piero ;
Eizirik, Decio L. ;
Cnop, Miriam .
DIABETES, 2009, 58 (12) :2851-2862
[6]   Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease [J].
de Vries, Aiko P. J. ;
Ruggenenti, Piero ;
Ruan, Xiong Z. ;
Praga, Manuel ;
Cruzado, Josep M. ;
Bajema, Ingeborg M. ;
D'Agati, Vivette D. ;
Lamb, Hildo J. ;
Barlovic, Drazenka Pongrac ;
Hojs, Radovan ;
Abbate, Manuela ;
Rodriquez, Rosa ;
Mogensen, Carl Erik ;
Porrini, Esteban .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (05) :417-426
[7]   Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease [J].
Docherty, Neil G. ;
le Roux, Carel W. .
EXPERIMENTAL PHYSIOLOGY, 2014, 99 (09) :1146-1153
[8]   Obesity and risk for chronic renal failure [J].
Ejerblad, Elisabeth ;
Fored, C. Michael ;
Lindblad, Per ;
Fryzek, Jon ;
McLaughlin, Joseph K. ;
Nyren, Olof .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (06) :1695-1702
[9]  
Felizardo Raphael Jose Ferreira, 2014, World J Nephrol, V3, P50, DOI 10.5527/wjn.v3.i3.50
[10]   Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity [J].
Glastras, Sarah J. ;
Chen, Hui ;
McGrath, Rachel T. ;
Zaky, Amgad A. ;
Gill, Anthony J. ;
Pollock, Carol A. ;
Saad, Sonia .
SCIENTIFIC REPORTS, 2016, 6